| Mapping of human brown adipose tissue in lean and obese young men BP Leitner, S Huang, RJ Brychta, CJ Duckworth, AS Baskin, S McGehee, ... Proceedings of the National Academy of Sciences 114 (32), 8649-8654, 2017 | 494 | 2017 |
| Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related … A Jha, A Ling, C Millo, G Gupta, B Viana, FI Lin, P Herscovitch, KT Adams, ... European journal of nuclear medicine and molecular imaging 45, 787-797, 2018 | 79 | 2018 |
| Precision medicine: an update on genotype/biochemical phenotype relationships in pheochromocytoma/paraganglioma patients G Gupta, K Pacak, AACE Adrenal Scientific Committee Endocrine Practice 23 (6), 690-704, 2017 | 67 | 2017 |
| Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway Y Pang, C Yang, J Schovanek, H Wang, P Bullova, V Caisova, G Gupta, ... Oncotarget 8 (14), 22313, 2017 | 32 | 2017 |
| Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature I Tena, G Gupta, M Tajahuerce, M Benavent, M Cifrián, A Falcon, ... Clinical Medicine Insights: Oncology 12, 1179554918763367, 2018 | 30 | 2018 |
| The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands … V Caisova, L Li, G Gupta, I Jochmanova, A Jha, O Uher, TT Huynh, ... Cancers 11 (5), 654, 2019 | 28 | 2019 |
| A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2 V617F positive polycythemia vera: a case report Y Pang, G Gupta, C Yang, H Wang, TT Huynh, Z Abdullaev, SD Pack, ... BMC cancer 18 (1), 1-6, 2018 | 19 | 2018 |
| Nonmosaic somatic HIF2A mutations associated with late onset polycythemia‐paraganglioma syndrome: Newly recognized subclass of polycythemia … Y Pang, G Gupta, A Jha, X Yue, H Wang, TT Huynh, A Li, L Li, E Baker, ... Cancer 125 (8), 1258-1266, 2019 | 12 | 2019 |
| Superiority of 68Ga-DOTATATE PET/CT to other functional and anatomic imaging modalities in the detection ofSDHD-related pheochromocytoma and paraganglioma-A comparative … A Jha, A Ling, C Millo, C Chen, G Gupta, B Viana, M Gonzales, K Adams, ... Journal of Nuclear Medicine 59 (supplement 1), 46-46, 2018 | 9 | 2018 |
| Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination S Nutalapati, G Gupta, GC Hildebrandt Clinical Case Reports 9 (11), e05035, 2021 | 3 | 2021 |
| PARP Inhibition to Enhance Response to Chemotherapy N Takebe, M Quinn, G Gupta, AP Chen Targeting Cell Survival Pathways to Enhance Response to Chemotherapy, 231-257, 2019 | 2 | 2019 |
| Self-reported adherence to lenalidomide as maintenance therpay for multiple myeloma after autologous stem cell transplantation. I Schlam, G Gupta, JH Essell Journal of Clinical Oncology 36 (15_suppl), e20046-e20046, 2018 | 1 | 2018 |
| Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of unknown significance: A case report G Gupta, JS Veedu, Z Chahine, C Iragavarapu Clinical Case Reports 12 (2), e8361, 2024 | | 2024 |
| The impact of CARE Frailty Index on overall survival in older adults with hepatocellular carcinoma. AA Ozluk, GR Williams, C Dai, M Malla, K Siwakoti, DA Outlaw, C Pywell, ... Journal of Clinical Oncology 42 (3_suppl), 462-462, 2024 | | 2024 |
| Are there any clinical factors associated with PRRT-refractoriness in NET patients? G Gupta, R Yadav, D Yan, L Anthony, R Ramirez, A Chauhan Endocrine Abstracts 98, 2023 | | 2023 |
| Use of gender-neutral language in clinical trial protocols in select cancers. G Gupta, Z Myint, D Yan, RA Patel Journal of Clinical Oncology 41 (16_suppl), 1574-1574, 2023 | | 2023 |
| Response to immune checkpoint inhibitor (ICI) rechallenge in patients with metastatic renal cell carcinoma who progressed on prior ICI: A systematic review and meta-analysis. G Gupta, D Yan, Z Myint Journal of Clinical Oncology 41 (16_suppl), 4547-4547, 2023 | | 2023 |
| Abstract CT221: Phase II of frontline maintenance rucaparib in combination with nivolumab in ES SCLC A Chauhan, J Kolesar, D Yan, Z Hao, R McGarry, J Villano, R Zinner, ... Cancer Research 83 (8_Supplement), CT221-CT221, 2023 | | 2023 |
| Management of bronchopulmonary neuroendocrine tumors G Gupta, R Ramirez, A Chauhan International journal of cancer care and delivery, 2022 | | 2022 |
| Abstract B90: Improved mice survival by reducing pheochromocytoma burden through activation of innate immunity using mannan and toll-like receptors V Caisova, G Gupta, I Jochmanova, A Jha, L Li, TT Huynh, Y Pang, ... Cancer Immunology Research 8 (4_Supplement), B90-B90, 2020 | | 2020 |
Karel PacakVerified email at mail.nih.gov
